Thioredoxin, a redox enzyme released in infection and inflammation, is a unique chemoattractant for neutrophils, monocytes, and T cells

Journal of Experimental Medicine

Volumn 189, Issue 11, 1999, Pages 1783-1789

  Bertini, Riccardo ^a   Howard, O M Zack ^b   Dong, Hui Fang ^b   Oppenheim, Joost J ^b   Bizzarri, Cinzia ^c   Sergi, Rita ^a   Caselli, Gianfranco ^a   Pagliei, Sabrina ^a   Romines, Brie ^d   Wilshire, Jennifer A ^d   Mengozzi, Manuela ^d   Nakamura, Hajime ^e   Yodoi, Junji ^e   Pekkari, Klas ^f   Gurunath, Ramanathan ^f   Holmgren, Arne ^f   Herzenberg, Leonore A ^d   Herzenberg, Leonard A ^d   Ghezzi, Pietro ^d,g  

^a Chemistry Section   (Italy)

^b NATIONAL CANCER INSTITUTE   (United States)

^c Consorzio Biolaq ^*  (Italy)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e KYOTO UNIVERSITY   (Japan)

^f KAROLINSKA INSTITUTE   (Sweden)

^g STANFORD UNIVERSITY   (United States)

Author keywords

Chemotaxis; HTLV 1; Migration; Thioredoxin

Indexed keywords

THIOREDOXIN;

ARTICLE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFLAMMATORY DISEASE; LYMPHOCYTE MIGRATION; MONOCYTE; NEUTROPHIL CHEMOTAXIS; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL;

EID: 0033532619     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.189.11.1783     Document Type: Article

References (53)

1. Holmgren, A. 1985. Thioredoxin. Annu. Rev. Biochem. 54: 237-271.
2. Holmgren, A. 1989. Thioredoxin and glutaredoxin systems. J. Biol. Chem. 264:13963-13966.
3. Holmgren, A., and M. Bjornstedt. 1995. Thioredoxin and thioredoxin reductase. Methods Enzymol. 252:199-208.
4. Nakamura, H., M. Matsuda, K. Furuke, Y. Kitaoka, S. Iwata, K. Toda, T. Inamoto, Y. Yamaoka, K. Ozawa, and J. Yodoi. 1994. Adult T cell leukemia-derived factor/human thioredoxin protects endothelial F-2 cell injury caused by activated neutrophils or hydrogen peroxide. Immunol. Lett. 42:75-80. (See published erratum 42:213.)
5. Sasada, T., S. Iwata, N. Sato, Y. Kitaoka, K. Hirota, K. Nakamura, A. Nishiyama, Y. Taniguchi, A. Takabayashi, and J. Yodoi. 1996. Redox control of resistance to cis-diamminedichloroplatinum (II) (CDDP): protective effect of human thioredoxin against CDDP-induced cytotoxicity. J. Clin. Invest. 97:2268-2276.
6. Yodoi, J., and T. Tursz. 1991. ADF, a growth-promoting factor derived from adult T cell leukemia and homologous to thioredoxin: involvement in lymphocyte immortalization by HTLV-I and EBV. Adv. Cancer Res. 57:381-411.
7. Yodoi, J., and T. Uchiyama. 1992. Diseases associated with HTLV-I: virus, IL-2 receptor dysregulation and redox regulation. Immunol. Today. 13:405-411.
8. Nakamura, H., K. Nakamura, and J. Yodoi. 1997. Redox regulation of cellular activation. Annu. Rev. Immunol. 15:351-369.
9. Ericson, M.L., J. Horling, V. Wendel-Hansen, A. Holmgren, and A. Rosen. 1992. Secretion of thioredoxin after in vitro activation of human B cells. Lymphokine Cytokine Res. 11: 201-207.
10. Tagaya, Y., Y. Maeda, A. Mitsui, N. Kondo, H. Matsui, J. Hamuro, N. Brown, K. Arai, T. Yokota, and H. Wakasugi. 1989. ATL-derived factor (ADF), an IL-2 receptor/Tac inducer homologous to thioredoxin; possible involvement of dithiol-reduction in the IL-2 receptor induction. EMBO (Eur. Mol. Biol. Organ.) J. 8:757-764. (See published erratum 13:2244.)
11. Wakasugi, N., Y. Tagaya, H. Wakasugi, A. Mitsui, M. Maeda, J. Yodoi, and T. Tursz. 1990. Adult T-cell leukemia-derived factor/thioredoxin, predicted by both human T-lymphotrophic virus type-1 and Epstein-Barr virus-transformed lymphocytes, acts as an autocrine growth factor and synergizes with interleukin 1 and interleukin 2. Proc. Natl. Acad. Sci. USA. 87:8282-8286.
12. Rubartelli, A., A. Bajetto, G. Allavena, E. Wollman, and R. Sitia. 1992. Secretion of thioredoxin by normal and neoplastic cells through a leaderless secretory pathway. J. Biol. Chem. 267:24161-24164.
13. Rubartelli, A., N. Bonifaci, and R. Sitia. 1995. High rates of thioredoxin secretion correlate with growth arrest in hepatoma cells. Cancer Res. 55:675-680.
14. Teshigawara, K., M. Maeda, K. Nishino, T. Nikaido, T. Uchiyama, M. Tsudo, Y. Wano, and J. Yodoi. 1985. Adult T leukemia cells produce a lymphokine that augments interleukin 2 receptor expression. J. Mol. Cell Immunol. 2:17-26.
15. Hori, K., M. Hirashima, M. Ueno, M. Matsuda, S. Waga, S. Tsurufuji, and J. Yodoi. 1993. Regulation of eosinophil migration by adult T cell leukemia-derived factor. J. Immunol. 151:5624-5630.
16. Silberstein, D.S., S. McDonough, M.S. Minkoff, and M.K. Balcewicz-Sablinsha. 1993. Human eosinophil cytotoxicity enhancing factor: eosinophil-stimulating and dithiol reductase activities of biosynthetic (recombinant) species with COOH-terminal deletions. J. Biol. Chem. 268:9138-9142.
17. Schenk, H., M. Vogt, W. Dröge, and K. Schulze-Osthoff. 1996. Thioredoxin as a potent costimulus of cytokine expression. J. Immunol. 156:765-771.
18. Nakamura, H., S. De Rosa, M. Roederer, M.T. Anderson, J.G. Dubs, J. Yodoi, A. Holmgren, and L.A. Herzenberg. 1996. Elevation of plasma thioredoxin levels in HIV-infected individuals. Int. Immunol. 8:603-611.
19. Maurice, M.M., H. Nakamura, E.A. van der Voort, A.I. van Vhet, F.J. Staal, P.P. Tak, F.C. Breedveld, and C.L. Verweij. 1997. Evidence for the role of an altered redox state in hypo-responsiveness of synovial T cells in rheumatoid arthritis. J. Immunol. 158:1458-1465.
20. Ren, X., M. Bjornstedt, B. Shen, M.L. Ericson, and A. Holmgren. 1993. Mutagenesis of structural half-cystine residues in human thioredoxin and effects on the regulation of activity by selenodiglutathione. Biochemistry. 32:9701-9708.
21. Holmgren, A., and F. Aslund. 1995. Glutaredoxin. Methods Enzymol. 252:283-292.
22. Gallegos, A., J.R. Gasdaska, C.W. Taylor, G.D. Paine-Murrieta, D. Goodman, P.Y. Gasdaska, M. Berggren, M.M. Briehl, and G. Powis. 1996. Transfection with human thioredoxin increases cell proliferation and a dominant-negative mutant thioredoxin reverses the transformed phenotype of human breast cancer cells. Cancer Res. 56:5765-5770.
23. Nakamura, H., J. Vaage, G. Valen, C.A. Padilla, M. Bjornstedt, and A. Holmgren. 1998. Measurements of plasma glutaredoxin and thioredoxin in healthy volunteers and during open-heart surgery. Free Radical Biol. Med. 24:1176-1186.
24. Falk, W., R.H. Goodwin Jr., and E.J. Leonard. 1980. A 48-well micro chemotaxis assembly for rapid and accurate measurement of leukocyte migration. J. Immunol. Methods. 33: 239-247.
25. Chertov, O., D.F. Michiel, L. Xu, J.M. Wang, K. Tani, W.J. Murphy, D.L. Longo, D.D. Taub, and J.J. Oppenheim. 1996. Identification of defensin-1, defensin-2, and CAP37/ azurocidin as T-cell chemoattractant proteins released from interleukin-8-stimulated neutrophils. J. Biol. Chem. 271: 2935-2940.
26. Anderson, M.T., N. Baumgarth, R.P. Haugland, R.M. Gerstein, T. Tjioe, and L.A. Herzenberg. 1998. Pairs of violet-light-excited fluorochromes for flow cytometric analysis. Cytometry. 33:435-444.
27. Roederer, M., S. De Rosa, R. Gerstein, M. Anderson, M. Bigos, R. Stovel, T. Nozaki, D. Parks, and L. Herzenberg. 1997. 8-color, 10-parameter flow cytometry to elucidate complex leukocyte heterogeneity. Cytometry. 29:328-339.
28. 2+ increase in human adherent monocytes. Blood. 86:2388-2394.
29. Brandolini, L., R. Bertini, C. Bizzarri, R. Sergi, G. Caselli, D. Zhou, M. Locati, and S. Sozzani. 1996. IL-1 beta primes IL-8-activated human neutrophils for elastase release, phospholipase D activity, and calcium flux. J. Leukocyte Biol. 59: 427-434.
30. Romano, M., R. Faggioni, M. Sironi, S. Sacco, B. Echtenacher, E. Di Santo, M. Salmona, and P. Ghezzi. 1997. Carrageenan-induced acute inflammation in the mouse air pouch synovial model. Role of tumor necrosis factor. Mediat. Inflamm. 6:1-7.
31. Yodoi, J., and T. Tursz. 1991. ADF, a growth-promoting factor derived from adult T cell leukemia and homologous to thioredoxin: involvement in lymphocyte immortalization by HTLV-I and EBV. Adv. Cancer Res. 57:381-411.
32. Saggioro, D., J.M. Wang, M. Sironi, W. Luini, A. Mantovani, and L. Chieco-Bianchi. 1991. Chemoattractant(s) in culture supernatants of HTLV-I-infected T-cell lines. AIDS Res. Hum. Retroviruses. 7:571-577.
33. Bertini, R., W. Luini, S. Sozzani, B. Bottazzi, P. Ruggiero, D. Boraschi, D. Saggioro, L. Chieco-Bianchi, P. Proost, J. van Damme, et al. 1995. Identification of MIP-1 alpha/ LD78 as a monocyte chemoattractant released by the HTLV-I-transformed cell line MT4. AIDS Res. Hum. Retroviruses. 11:155-160.
34. Wu, D., G.J. LaRosa, and M.I. Simon. 1993. G protein-coupled signal transduction pathways for interleukin-8. Science. 261:101-103.
35. Kuang, Y., Y. Wu, H. Jiang, and D. Wu. 1996. Selective G protein coupling by C-C chemokine receptors. J. Biol. Chem. 271:3975-3978.
36. Arai, H., C.L. Tsou, and I.F. Charo. 1997. Chemotaxis in a lymphocyte cell line transfected with C-C chemokine receptor 2B: evidence that directed migration is mediated by βγ dimers released by activation of Gαi-coupled receptors. Proc. Natl. Acad. Sci. USA. 94:14495-14499.
37. Debarbieux, L., and J. Beckwith. 1998. The reductive enzyme thioredoxin 1 acts as an oxidant when it is exported to the Escherichia coli periplasm. Proc. Natl. Acad. Sci. USA. 95: 10751-10756.
38. Goldberg, M.A., S.P. Dunning, and H.E. Bunn. 1988. Regulation of erythropoietin gene: evidence the oxygen sensor is a heme protein. Science. 242:1412-1415.
39. Decottignies, P., J.M. Schmitter, J.P. Jacquot, S. Dutka, A. Picaud, and P. Gadal. 1990. Purification, characterization, and complete amino acid sequence of a thioredoxin from a green alga, Chlamydomonas reinhardtii. Arch. Biochem. Biophys. 280:112-121.
40. Wollman, E.E., A. Kahan, and D. Fradelizi. 1997. Detection of membrane associated thioredoxin on human cell lines. Biochem. Biophys. Res. Commun. 230:602-606.
41. Gasdaska, J.R., M. Berggren, and G. Powis. 1995. Cell growth stimulation by the redox protein thioredoxin occurs by a novel helper mechanism. Cell Growth. Differ. 6:1643-1650.
42. Biguet, C., N. Wakasugi, Z. Mishal, A. Holmgren, S. Chouaib, T. Tursz, and H. Wakasugi. 1994. Thioredoxin increases the proliferation of human B-cell lines through a protein kinase C-dependent mechanism. J. Biol. Chem. 269: 28865-28870.
43. Sahaf, B., A. Soderberg, G. Spyrou, A.M. Barral, K. Pekkari, A. Holmgren, and A. Rosen. 1997. Thioredoxin expression and localization in human cell lines: detection of full-length and truncated species. Exp. Cell Res. 236:181-192.
44. Endoh, M., T. Kunishita, and T. Tabira. 1993. Thioredoxin from activated macrophages as a trophic factor for central cholinergic neurons in vitro. Biochem. Biophys. Res. Commun. 192:760-765.
45. Buetler, T.M. 1998. Identification of glutathione S-transferase isozymes and gamma-glutamylcysteine synthetase as negative acute-phase proteins in rat liver. Hepatology. 28: 1551-1560.
46. Sachi, Y., K. Hirota, H. Masutani, K. Toda, T. Okamoto, M. Takigawa, and J. Yodoi. 1995. Induction of ADF/TRX by oxidative stress in keratinocytes and lymphoid cells. Immunol. Lett. 44:189-193.
47. Tomimoto, H., I. Akiguchi, H. Wakita, J. Kimura, K. Hori, and J. Yodoi. 1993. Astroglial expression of ATL-derived factor, a human thioredoxin homologue, in the gerbil brain after transient global ischemia. Brain Res. 625:1-8.
48. Lippoldt, A., C.A. Padilla, H. Gerst, B. Andbjer, E. Richter, A. Holmgren, and K. Fuxe. 1995. Localization of thioredoxin in the rat brain and functional implications. J. Neurosci. 15:6747-6756.
49. Hechtman, D.H., M.I. Cybulsky, H.J. Fuchs, J.B. Baker, and M.A. Gimbrone, Jr. 1991. Intravascular IL-8. Inhibitor of polymorphonuclear leukocyte accumulation at sites of acute inflammation. J. Immunol. 147:883-892.
50. Simonet, W.S., T.M. Hughes, H.Q. Nguyen, L.D. Trebasky, D.M. Danilenko, and E.S. Medlock. 1994. Long-term impaired neutrophil migration in mice overexpressing human interleukin-8. J. Clin. Invest. 94:1310-1319.
51. Rutledge, B.J., H. Rayburn, R. Rosenberg, R.J. North, R.P. Gladue, C.L. Corless, and B.J. Rollins. 1995. High level monocyte chemoattractant protein-1 expression in transgenic mice increases their susceptibility to intracellular pathogens. J. Immunol. 155:4838-4843.
52. Lazzarin, A., C. Uberti Foppa, M. Galli, A. Mantovani, G. Poli, F. Franzetti, and R. Novati. 1986. Impairment of polymorphonuclear leucocyte function in patients with acquired immunodeficiency syndrome and with lymphadenopathy syndrome. Clin. Exp. Immunol. 65:105-111.
53. Poli, G., B. Bottazzi, R. Acero, L. Bersani, V. Rossi, M. Introna, A. Lazzarin, M. Galli, and A. Mantovani. 1985. Monocyte function in intravenous drug abusers with lymphadenopathy syndrome and in patients with acquired immunodeficiency syndrome: selective impairment of chemotaxis. Clin. Exp. Immunol. 62:136-142.